What is the recommended dose of Buproprion (Wellbutrin) for treating depression and smoking cessation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bupropion Dosing for Depression and Smoking Cessation

For depression, bupropion should be initiated at 200 mg/day (100 mg twice daily), increased after 3 days to 300 mg/day (100 mg three times daily), with a maximum dose of 450 mg/day; for smoking cessation, the recommended dose is 150 mg/day for 3 days, then 300 mg/day. 1

Depression Treatment Dosing

Initial Dosing and Titration

  • Start with 200 mg/day, given as 100 mg twice daily 1
  • After 3 days, increase to 300 mg/day, given as 100 mg three times daily with at least 6 hours between doses 1
  • For patients showing no clinical improvement after several weeks at 300 mg/day, dosing may be increased to a maximum of 450 mg/day 1
  • Maximum single dose should not exceed 150 mg to minimize seizure risk 1

Formulation Options

  • Immediate-release (IR): Administered three times daily (maximum 450 mg/day) 2
  • Sustained-release (SR): Administered twice daily (maximum 400 mg/day) 3
  • Extended-release (XR): Administered once daily 2

Duration of Treatment

  • Acute episodes of depression typically require several months or longer of antidepressant treatment beyond the initial response 1
  • Full efficacy is usually attained after 4 weeks of treatment 3

Smoking Cessation Dosing

  • Typically initiated at 150 mg/day for 3 days, then increased to 300 mg/day (150 mg twice daily) 4
  • Treatment is generally continued for 7-12 weeks 3
  • Bupropion has been approved for smoking cessation and can have a combined role in treating nicotine cravings and depression 3

Dose Adjustments for Special Populations

Hepatic Impairment

  • Mild impairment (Child-Pugh score 5-6): Consider reducing dose and/or frequency 1
  • Moderate to severe impairment (Child-Pugh score 7-15): Maximum dose should be 75 mg/day 1

Renal Impairment

  • For GFR less than 90 mL/min: Consider reducing dose and/or frequency 1
  • For moderate to severe renal impairment: Reduce dose by 50% 5
  • Avoid in end-stage renal disease 5

Important Safety Considerations

Seizure Risk

  • Increase dose gradually to minimize seizure risk 1
  • Do not exceed 100 mg/day increase in a 3-day period 1
  • Contraindicated in patients with seizure disorders or conditions that lower seizure threshold 5

Cardiovascular Monitoring

  • Regular monitoring of blood pressure and heart rate is necessary, especially during the first 12 weeks 5
  • Contraindicated in patients with uncontrolled hypertension 5

Drug Interactions

  • Allow at least 14 days between discontinuing MAOIs and starting bupropion 1
  • Similarly, allow at least 14 days after stopping bupropion before starting an MAOI 1
  • Contraindicated for use with MAOIs due to risk of hypertensive reactions 5, 1

Administration Guidelines

  • Bupropion tablets should be swallowed whole, not crushed, divided, or chewed 1
  • May be taken with or without food 1

Common Side Effects

  • Dry mouth, insomnia, headache, nausea, anxiety/jitteriness, decreased appetite 5, 3
  • Weight loss is common (0.5-1.0 kg on average) 6
  • Less likely to cause sexual dysfunction compared to SSRIs 2
  • May actually improve SSRI-associated sexual dysfunction when used in combination 4

Discontinuation

  • Gradual tapering is recommended when discontinuing bupropion 5
  • Reduction to 150 mg once daily for 1-2 weeks before complete discontinuation is suggested 5

Bupropion offers advantages of minimal weight gain and less sexual dysfunction compared to other antidepressants, making it a valuable option for both depression treatment and smoking cessation. However, careful attention must be paid to seizure risk and cardiovascular effects, particularly during dose titration.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.